Insulin inhibits rat hippocampal neurones via activation of ATP-sensitive K+ and large conductance Ca2+-activated K+ channels

Neuropharmacology

Volumn 44, Issue 7, 2003, Pages 855-863

  O'Malley, Dervla ^a   Shanley, Lynne J ^a   Harvey, Jenni ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

BK channels; Ca2+ oscillations; Insulin; KATP channels; MAPK; PI 3 kinase

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CHARYBDOTOXIN; DIAZOXIDE; GLIBENCLAMIDE; IBERIOTOXIN; INSULIN; INSULIN RECEPTOR; MAGNESIUM ION; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; SYNAPSIN I; WORTMANNIN;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM SIGNALING; CELL CULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENDRITE; ENZYME ACTIVATION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INCUBATION TIME; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SOMATIC CELL;

EID: 0037410527     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00081-9     Document Type: Article

References (44)

1. Abele A.E., Scholz K.P., Scholz W.K., Miller R.J. Excitotoxicity induced by enhanced neurotransmission in cultured hippocampal neurons. Neuron. 4:1990;413-419.
2. Abele A.E., Miller R.J. Potassium channel activators abolish excitotoxicity in cultured hippocampal neurons. Neuroscience Letters. 115:1990;195-200.
3. Alessi D.R., Cuendo A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro. Journal of Biological Chemistry. 270:1995;27489-27494.
4. Altura B.M., Altura B.T. Association of alcohol in brain injury, headaches and stroke with brain tissue and serum levels of ionised magnesium: a review of recent findings and mechanisms of action. Alcohol. 19:1999;119-130.
5. Avruch J., Khokhlatchev A., Kyriakis J.M., Luo Z., Tzivion G., Vavvas D., Zhang X.F. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Progress in Hormone Research. 56:2001;127-155.
6. Baskin D.G., Schwartz M.W., Sipols A.J., D'Alessi D.A., Goldstein B.J., White M.F. Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology. 134:1994;1952-1955.
7. Beilharz E.J., Russo V.C., Butler G., Baker N.L., Connor B., Sirimanne E.S., Dragunow M., Werther G.A., Gluckman P.D., Williams C.E., Scheepens A. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res. Mol. Brain Res. 59:1998;119-134.
8. Bell D.S. Stroke in the diabetic patient. Diabetes Care. 17:1994;213-219.
9. Clarke D.W., Mudd L., Boyd F.T., Fields M., Raizada M.K. Insulin is released from rat brain neuronal cells in culture. Journal of Neurochemistry. 47:1986;831-836.
10. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemistry Journal. 351:2000;95-105.
11. 2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proceedings of the National Academy of Sciences of the USA. 24:1998;14482-14487.
12. Dore S., Kar S., Quirion R. Rediscovering an old friend, IGF-1: potential use in the treatment of neurogenerative diseases. TINS. 20:1997;326-331.
13. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. Journal of Biological Chemistry. 273:1998;18623-18632.
14. Folli F., Bonfanti L., Renard E., Khan R., Merighi A. Insulin receptor substrate-1 (IRS-1) distribution in the central nervous system. Journal of Neuroscience. 14:1994;6412-6416.
15. Galvez A., Gimenez-Gallego G., Reuben J.P., Roy-Contancin L., Feigenbaum P., Kaczorowski G.J., Garcia M.L. Purification and characterisation of a unique, potent, peptidyl probe for the high condutance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. Journal Biological Chemistry. 265:1990;11083-11090.
16. Gispen W.H., Biessels G.-J. Cognition and synaptic plasticity in diabetes mellitus. TINS. 23:2000;542-549.
17. Guyot L.L., Diaz F.G., O'Regan M.H., Sang D., Phiilis J.W. The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during stretozotocin-induced hyperglycemic ischemia. Brain Res. 872:2000;29-36.
18. Harden C.L., Rosenbaum D.H., Daras M. Hyperglycaemia presenting with occipital seizures. Epilepsia. 3:1991;215-220.
19. Heidenreich K.A., de Vellis G., Gilmore P.R. Functional properties of the subtype of insulin receptor found on neurons. J. Neurochem. 51:1998;878-887.
20. + currents recorded from an insulin-secreting cell line. British Journal Pharmacology. 97:1989;1039-1050.
21. Lui L., Brown J.C., Webster W.W., Morrisett R.A., Monaghan D.T. Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neuroscience Letters. 192:1995;5-8.
22. McLeod J.R., Shen M., Kim D.J., Thayer S.A. Neurotoxicity mediated by aberrant patterns of synaptic activity between rat hippocampal neurons in culture. Journal of Neurophysiology. 80:1998;2688-2698.
23. + channels from mammalian skeletal muscle. Nature. 313:1985;316-318.
24. Myers M.G., White M.F. Insulin signal transduction and the IRS proteins. Annual Review of Pharmacology and Toxicology. 36:1996;615-658.
25. + channels by novel benimidazolone. European Journal of Pharmacology. 251:1994;53-59.
26. Powis G., Bonjouklion R., Berggren M.M., Gallegos A., Abraham R., Ashendel C., Zalkow L., Matter W.F., Dodge J., Grindley G. Wortmannin, a potent and selective inhibitor of phosphatidylinositol 3-kinase. Cancer Research. 54:1994;2419-2423.
27. 2+ signalling in rat hippocampal neurons. J. Neurosci. 20:2000;8628-8636.
28. Schechter R., Whitmire J., Holtzclaw L., George M., Harlow R., Devaskar S.U. Developmental regulation of insulin in the mammalian central nervous system. Brain Research. 582:1992;27-37.
29. Shanley L.J., Irving A.J., Harvey J. Insulin inhibits spontaneous calcium oscillations in cultured hippocampal neurones. Journal of Physiology. 536P:2001;119P.
30. Shanley L.J., O'Malley D., Irving A.J., Ashford M.L.J., Harvey J. Leptin inhibits epileptiform-like activity in rat hippocampal neurones via PI 3-kinase-driven activation of BK channels. Journal of Physiology. 545:(3):2002;933-944.
31. + channels. Nature Neuroscience. 5:(4):2002;299-300.
32. Shepherd P.R., Withers D.J., Siddle K. Phosphoinositide 3-kinase: the key switch in insulin signalling. Biochemistry Journal. 333:1998;471-490.
33. Skeberdis V.A., Lan J., Zheng X., Zukin R.S., Bennett M.V. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proceedings of the National Academy of Sciences. 98:2001;3561-3566.
34. + channels in hypothalamic neurons of lean but not obese rats. Nature Neuroscience. 3:2000;757-758.
35. Unger J.W., Livingston J.N., Moss A.M. Insulin receptors in the central nervous system: localisation, signalling and functional aspects. Progress in Neurobiology. 36:1991;343-362.
36. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry. 269:1994;5241-5248.
37. A receptors to postsynaptic domains by insulin. Nature. 388:1997;686-690.
38. Wei L.T., Matsumoto H., Rhoads D.E. Release of immunoreactive insulin from rat brain synaptosomes under depolarising conditions. Journal of Neurochemistry. 54:1990;831-836.
39. Weiland M., Bahr F., Hohne M., Schurmann A., Ziehm D., Joost H.G. The signalling potential of the receptors for insulin and insulin-like growth factor 1 (IGF-1) in 3t3-L1 adipocytes: comparison of glucose transport activity, induction of oncogenes c-fos, glucose transporter mRNA and DNA synthesis. Journal of Cell Physiology. 149:1991;428-435.
40. Whiting S., Camfield P., Arab D., Salisbury S. Insulin-dependent diabetes mellitus presenting in children as frequent, medically unresponsive, partial seizures. Journal of Child Neurology. 12:1997;178-180.
41. Wicklegren I. Tracking insulin to the mind. Science. 280:1998;517-519.
42. Zhao W., Alkon D.L. Role of insulin and insulin receptors in learning and memory. Molecular and Cellular Endocrinology. 177:2001;125-134.
43. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., Alkon D.L. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation and signalling molecules in the hippocampus of water maze trained rats. Journal of Biological Chemistry. 274:1999;34893-34902.
44. Zhou Q., Xiao M., Nicoll R.A. Contribution of the cytoskeleton to the internalisation of AMPA receptors. Proceedings of the National Academy of Sciences. 98:2001;1261-1266.